Nebraska Methodist Hospital — Omaha, Nebraska

Nebraska Methodist Hospital is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Nebraska Methodist Hospital has participated in 349 clinical trials with 142 currently active.

Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Sponsors: GOG Foundation, Eli Lilly and Company, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Hospital?

Nebraska Methodist Hospital has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Hospital conducted?

Nebraska Methodist Hospital has 349 clinical trials on record, with 142 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Is Nebraska Methodist Hospital accredited by Crixeo Health?

Nebraska Methodist Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.